@misc{indiciae6d8f44302c2c,
  title = {Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study.},
  author = {David A Sallman and Guillermo Garcia-Manero and Naval Daver and Camille N Abboud and Eytan Stein and Karilyn Larkin and Anna B Halpern and Shannon R McCurdy and Monzr M Al Malki and Guru Subramanian Guru Murthy and Lewis R Silverman and Richard A Larson and Peter Greenberg and Ivana Gojo and Tomasz Wrobel and Uwe Platzbecker and Cecily Forsyth and Pankit Vachhani and Mei Dong and Jiang Shao and Lisa D S Johnson and Anderson Tan and Calvin Lee and Parul Doshi and Paresh Vyas and Andrew H Wei},
  year = {2026},
  doi = {10.1200/jco-25-00617},
  url = {https://pubmed.ncbi.nlm.nih.gov/42441929/},
  note = {Source identifier: 42441929}
}